Antidiabetic thiazolidinediones block the inhibitory effect of tumor necrosis factor-α on differentiation, insulin-stimulated glucose uptake, and gene expression in 3T3-L1 cells

Endocrinology

Volumn 136, Issue 4, 1995, Pages 1478-1481

  Szalkowski, Deborah ^a   White Carrington, Sylvia ^a   Berger, Joel ^a   Zhang, Bel ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIGLITAZONE; ENGLITAZONE; FATTY ACID BINDING PROTEIN; GLUCOSE TRANSPORTER; INSULIN; LIPOPROTEIN LIPASE; PIOGLITAZONE; THIAZOLIDINE DERIVATIVE; TROGLITAZONE; TUMOR NECROSIS FACTOR ALPHA;

ADIPOSE TISSUE; ARTICLE; CELL DIFFERENTIATION; ENERGY BALANCE; GENE EXPRESSION; GLUCOSE TRANSPORT; HUMAN; HUMAN CELL; INSULIN RESISTANCE; PRIORITY JOURNAL; REGULATORY MECHANISM;

3T3 CELLS; ANIMAL; CARRIER PROTEINS; CELL DIFFERENTIATION; DEOXYGLUCOSE; GENE EXPRESSION; GLUCOSE; HYPOGLYCEMIC AGENTS; INSULIN; MICE; MONOSACCHARIDE TRANSPORT PROTEINS; RNA, MESSENGER; THIAZOLES; TUMOR NECROSIS FACTOR;

EID: 0028916523     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/endo.136.4.7895657     Document Type: Article

References (52)

1. Old LJ 1985 Tumor necrosis factor (TNF). Science 230:630-632
2. Beutler B, Cerami A1986 Cachectin and tumor necrosis factor as two sides of the same biological coin. Nature 320:584-588
3. Bennegard K, Lundgren F, Lundholm K1986 Mechanism of insulin resistance in cancer associated malnutrition. Clin Physiol 6:539-547
4. Offner F, Philippe J, Vogelares D, Colardyn F, Baele G, Baudrihaye M, Vermeulen A, Lerous-Roels G1990 Serum tumor necrosis factor levels in patients with infectious disease and septic shock. J Lab Clin Med 116:100-105
5. Shangraw RE, Jahoor F, Miyoshi H, Neff WA, Stuart CA, Herndon DN, Wolfe RR 1989 Differentiation between septic and postbum insulin resistance. Metabolism 38:983-989
6. Van der Poll T, Romijn JA, Endert E, Bonn JJJ, Buller HR, Sauerwein HP 1991 Tumor necrosis factor mimics the metabolic response to acute infection in healthy humans. Am J Physiol 261:E457-E465
7. McCall JL, Tuckey JA, Parry BR 1992 Serum tumor necrosis factor α and insulin resistance in gastrointestinal cancer. Br J Surg 79:1361-1363
8. Tracey KJ, Cerami A 1992 Tumor necrosis factor and regulation of metabolism in infection: role of systemic vs. tissue levels. Proc Soc Exp Biol Med 200:233-239
9. Lang CH, Dobrescu C, Bagby GJ 1992 Tumor necrosis factor impairs insulin action on peripheral glucose disposal and hepatic glucose output. Endocrinology 130:43-52
10. Hotamisligil GS, Shargill NS, Spiegelman BM 1993 Adipose expression of tumor necrosis factor-a: direct role in obesity-linked insulin resistance. Science 259:87-90
11. Hofmann C, Lorenz K, Braithwaite SS, Colca JR, Palazuk BJ, Hotamisligil GS, Spiegelman BM 1994 Altered gene expression for tumor necrosis factor-a and its receptors during drug and dietary modulation of insulin resistance. Endocrinology 134:264-270
12. Pape ME, Kim K-H 1988 Effect of tumor necrosis factor on acetyl-coenzyme A carboxylase gene expression and preadipocyte differentiation. Mol Endocrinol 2:395-403
13. Cornelius P, Enerback S, Bjursell G, Olivecrona T, Pekala PH 1988 Regulation of lipoprotein lipase mRNA content in 3T3-L1 cells by tumor necrosis factor. Biochem J 249:765-769
14. Zechner R, Newman TC, Sherry B, Cerami A, Breslow JL 1988 Recombinant human cachectin/tumor necrosis factor but not inter-leukin-la downregulates lipoprotein lipase gene expression at the transcriptional level in mouse 3T3-L1 adipocytes. Mol Cell Biol 8:2394-2401
15. Min HY, Spiegelman BM 1986 Adipsin, the adipocyte serine protease: gene structure and control of expression by tumor necrosis factor. Nucleic Acids Res 14:8879-8892
16. Stephens JM, Pekala PH 1991 Transcriptional repression of the GLUT1 and C/EBP genes in 3T3-L1 adipocytes by tumor necrosis factor-a. J Biol Chem 266:21839-21845
17. Stephens JM, Pekala PH 1992 Transcriptional repression of the GLUT1 and C/EBP genes in 3T3-L1 adipocytes by tumor necrosis factor-a: regulation is coordinate and independent of protein synthesis. J Biol Chem 267:13580-13584
18. Fryer LG, Baldwin SA, Kruszynska YT1993 Depletion of adipocyte glucose transporter (GLUT4) but normal skeletal muscle GLUT4 expression in the insulin resistant high fat fed rat. Diabetes Nutr Metab 6:241-250
19. Garvey WT, Huecksteadt TP, Matthaei S, Olefsky JM 1988 Role of glucose transporters in the cellular insulin resistance of type II noninsulin-dependent diabetes mellitus. J Clin Invest 81:1528-1536
20. Garvey WT, Malanu L, Huecksteadt TP, Bimbaum MJ, Molina JM, Ciaraldi TP 1991 Pretranslational suppression of a glucose transporter protein causes insulin resistance in adipocytes from patients with non-insulin-dependent diabetes mellitus and obesity. J Clin Invest 87:1072-1081
21. Sinha MK, Raineri-Maldonado C, Buchanan C, Pories WJ, Carter-Su C, Pilch PF, Caro JF1991 Adipose tissue glucose transports in NIDDM: decreased level of muscle/fat isoform. Diabetes 40:472-477
22. Lebobitz HE 1993 Insulin mimetic and insulin-sensitizing drugs. Diabetes Res Clin Pract 20:89-91
23. Chang AY, Wyse BM, Gilchrist BJ, Peterson T, Diani AR 1983 Ciglitazone, a new hypoglycemic agent. I. Studies in ob/ob and db/db mice, diabetic Chinese hamsters, and normal and strepto-zocin-diabetic rats. Diabetes 32:830-838
24. Fujita T, Sugiyama Y, Taketomi S, Sohda T, Kawamatsu Y, Iwat-suka H, Suzuoki Z 1983 Reduction of insulin resistance in obese and/or diabetic animal by 5[4-(l-methylcyclohexylmethoxy)ben-zyl]-thiazolidine-2, 4-dione (ADD-3878, U-63, 287, ciglitazone), a new antidiabetic agent. Diabetes 32:804-810
25. Sugiyama Y, Shimura Y, Ikeda H 1990 Effect of pioglitazone on hepatic and peripheral insulin resistance in Wistar fatty rats. Arz-neim Forsch 40:436-440
26. Blackmore PF, McPherson RK, Stevenson RW 1993 Actions of the novel antidiabetic englitazone in rat hepatocytes. Metabolism 42: 1583-1587
27. Kohanski RA, Frost SC, Lane MD 1986 Insulin-dependent phosphorylation of the insulin receptor-protein kinase and activation of glucose transport in 3T3-L1 adipocytes. J Biol Chem 261:12272-12281
28. Sambrook J, Fritsch EF, Maniatis T 1989 Molecular Cloning-A Laboratory Manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor
29. Strout HV, Vicario PP, Biswas C, Saperstein R, Brady EJ, Pilch PF, Berger J 1990 Vanadate treatment of streptozoticin diabetic rats restores expression of the insulin-responsive glucose transporter in skeletal muscle. Endocrinology 126:2728-2732
30. Clancy BM, Czech MP1990 Hexose transport stimulation and membrane redistribution of glucose transporter isoforms in response to cholera toxin, dibutyryl cyclic AMP, and insulin in 3T3-L1 adipocytes. J Biol Chem 265:12434-12443
31. Calderhead DM, Kitagawa K, Tanner LI, Holman GD, Lienhard GE1990 Insulin regulation of the two glucose transporters in 3T3-L1 adipocytes. J Biol Chem 265:13800-13808
32. Bemlohr DA, Angus CW, Lane MD, Bolanowski MA, Kelly TJ Jr 1984 Expression of specific mRNAs during adipose differentiation: identification of an mRNA encoding a homologue of myelin P2 protein, Proc Natl Acad Sci USA 81:5468-5472
33. Kletzein RF, Foellmi LA, Harris PKW, Wyse BM, Clarke SD 1992 Adipocyte fatty acid-binding protein: regulation of gene expression in vivo and in vitro by an insulin-sensitizing agent. Mol Pharmacol 42:558-562
34. Spiegelman BM, Choy L, Hotamisligil GS, Graves RS, Tontonoz P 1993 Regulation of adipocyte gene expression in differentiation and syndromes of obesity/diabetes. J Biol Chem 268:6823-6826
35. Weiner FR, Shah A, Smith PJ, Rubin CS1989 Regulation of collagen gene expression in 3T3-L1 cells. Effects of adipocyte differentiation and tumor necrosis factor a. Biochemistry 28:4094-4099
36. Torti FM, Torti SV, Larrick JW, Ringold GM 1989 Modulation of adipocyte differentiation by tumor necrosis factor and transforming growth factor beta. J Cell Biol 108:1105-1113
37. Petruschke TH, Hauner H 1993 Tumor necrosis factor-a prevents the differentiation of human adipocyte precursor cells and causes delipidation of newly developed fat cells. J Clin Endocrinol Metab 76:742-747
38. Bell GI, Kayano T, Buse JB, Burant CF, Takeda J, Lin D, Fukumoto H, Seino S 1990 Molecular biology of mammalian glucose transporters. Diabetes Care 13:198-208
39. Simpson IA, Cushman SW 1986 Hormonal regulation of mammalian glucose transport. Annu Rev Biochem 55:1059-1089
40. Yang J, Clark AE, Kozka IJ, Cushman SW, Holman GD 1992 Development of an intracellular pool of glucose transporters in 3T3-L1 cells. J Biol Chem 267:10393-10399
41. Evans DA, Jacobs DO, Wilmore DW 1989 Tumor necrosis factor enhances glucose uptake by peripheral tissues. Am J Physiol 257: R1182-R1189
42. Cornelius P, Marlowe M, Lee MD, Pekala PH 1990 The growth factor-like effects of tumor necrosis-α. Stimulation of glucose transport activity and induction of glucose transporter and immediate early gene expression in 3T3-L1 preadipocytes. J Biol Chem 265:20506-20516
43. Umek RM, Friedman AD, McKnight SL 1991 CCAAT-enhancer binding protein: a component of a differentiation switch. Science 251:288-292
44. Samuelsson L, Stromberg K, Vikman K, Bjursell G, Enerback S 1991 The CCAAT/enhancer binding protein and its role in adipocyte differentiation: evidence for direct involvement in terminal development. EMBO J 10:3787-3793
45. Cheneval D, Christy RJ, Geiman D, Cornelius P, Lane MD 1991 Cell-free transcription directed by the 422 adipose P2 gene promoter: activation by the CCAAT/enhancer binding protein. Proc Natl Acad Sci USA 88:8465-8469
46. Ron D, Brasier AR, McGehee Jr RE, Habener JF 1992 Tumor necrosis factor-induced reversal of adipocytic phenotype of 3T3-L1 cells is preceded by a loss of nuclear CCA AT/enhancer binding protein (C/EBP). J Clin Invest 89:223-233
47. Hiragun A, Sato M, Mitsui H 1988 Preadipocyte differentiation in vitro: identification of a highly active adipogenic agent. J Cell Physiol 134:124-130
48. Sandouk T, Reda D, Hofmann C 1993 Antidiabetic agent pioglitazone enhances adipocyte differentiation of 3T3-F442A cells. Am J Physiol 264:C1600-C1608
49. Hofmann C, Lorenz K, Colca JR 1991 Glucose transport deficiency in diabetic animals is corrected by treatment with the oral antihy-perglycemic agent pioglitazone. Endocrinology 129:1915-1925
50. Sandouk T, Reda D, Hofmann C 1992 The antidiabetic agent pioglitazone increases expression of glucose transporters in 3T3-F442A cells by increasing messenger ribonucleic acid transcript stability. Endocrinology 133:352-359
51. Feinstein R, Kanety H, Papa MA, Lunenfeld B, Karasik A 1993 Tumor necrosis factor-a suppresses insulin-induced tyrosine phosphorylation of insulin receptor and its substrates. J Biol Chem 268: 26055-26058
52. Hotamisligil GS, Murray DL, Choy LN, Spiegelman BM 1994 Tumor necrosis factor a inhibits signaling from the insulin receptor. Proc Natl Acad Sci USA 91:4854-4858